CompaniesEpirus Biopharmaceuticals

Epirus Biopharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

BankruptBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

548

By Phase

PHASE3: 1

By Status

UNKNOWN: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT02683564Lead Sponsor

BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study

548 participants

Started: Feb 29, 2016

Funding History (20)

8-K

Aug 1, 2016

8-K

Jul 25, 2016

8-K

Jul 1, 2016

8-K

Jun 14, 2016

8-K

May 9, 2016

8-K

Mar 15, 2016

8-K

Mar 1, 2016

8-K

Feb 9, 2016

8-K/A

Nov 16, 2015

8-K

Nov 16, 2015